ERC
Scope Biosciences Point-of-Care CRISPR MDx Wins €2.5M European Innovation Council Grant
The firm's ScopeDx sample-to-answer isothermal molecular diagnostic system uses CRISPR technologies for clinical diagnostic and agricultural testing.
The researchers have been developing supramolecular assays based on chemiluminescent chemosensors that can detect metabolites in saliva, blood, and urine.